
‘Early treatment is key to survival in prostate cancer, and Xtandi has made it possible’
Prostate cancer, the number one urological cancer in Korea, continues to increase the number of patients every year due to rapid aging and Westernized dietary habits. Although prostate cancer initially responds effectively to androgen deprivation therapy ( …